Concepedia

Author

Shreerang Bhide

Institute of Cancer ResearchORCID

Also Known As

S A BHIDE, S A Bhide, S Bhide, S. A. Bhide, S. Bhide, S.A. Bhide, Sampada Bhide, Shekhar Bhide, Shreerang A Bhide, Shreerang A. Bhide

182

Publications

5.7K

Citations

38

H-Index

73

Concepts

All Affiliations

Institute of Cancer ResearchRoyal Marsden NHS Foundation TrustRoyal Marsden HospitalUniversity College LondonSt James's University Hospital
SB

About

Shreerang Bhide is an author at Institute of Cancer Research specializing in medicine, radiation oncology, and head and neck cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

22

926

2

Health Sciences

14

16

663

3

Engineering

2

2

150

4

Natural Sciences

2

2

150

5

Biomedical Engineering

1

1

131

Shreerang Bhide

×

63

Publications

4.9K

Citations

34

H-Index

YearCitations

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

Christopher M. Nutting, James P. Morden, Kevin J. Harrington,

The Lancet Oncology

2011

1.7K

Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck

Kevin J. Harrington, Mohan Hingorani, Mary Anne Tanay,

Clinical Cancer Research

2010

259

Weekly Volume and Dosimetric Changes During Chemoradiotherapy With Intensity-Modulated Radiation Therapy for Head and Neck Cancer: A Prospective Observational Study

Shreerang Bhide, Mark Davies, Kevin Burke,

International Journal of Radiation Oncology*Biology*Physics

2010

236

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Annika Fendler, Scott T.C. Shepherd, Lewis Au,

Nature Cancer

2021

177

Reduce in Variation and Improve Efficiency of Target Volume Delineation by a Computer-Assisted System Using a Deformable Image Registration Approach

K. S. Clifford Chao, Shreerang Bhide, Hansen Chen,

International Journal of Radiation Oncology*Biology*Physics

2007

131

Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma

Jen Y. Lee, Isaac García-Murillas, Rosalind Cutts,

British Journal of Cancer

2017

126

Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy

Jamie Dean, Kee H. Wong, Liam Welsh,

Radiotherapy and Oncology

2016

110

DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer

Imran Petkar, Keith Rooney, Justin Roe,

BMC Cancer

2016

109

Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei

Magnus T. Dillon, Holly E. Barker, Malin Pedersen,

Molecular Cancer Therapeutics

2016

108

Enhanced <i>In vitro</i> and <i>In vivo</i> Cytotoxicity of Combined Reovirus and Radiotherapy

Katie Twigger, Laura Vidal, Christine L. White,

Clinical Cancer Research

2008

103

Page 1